@misc{indiciaee848b464686c,
  title = {Homologous recombination deficiency and tumor suppressor heterozygosity mediate resistance to front-line therapy in breast cancer},
  author = {Safonov, A. and Marra, A. and Bandlamudi, C. and O'Leary, B. and Wubbenhorst, B. and Moiso, E. and Lee, M. and Donoghue, M. and An, J. A.-R. and Will, M. and Pareka, F. and Ahmed, M. and Nizialek, E. and Lukashchuk, N. and Sofianopoulou, E. and Liu, Y. and Huang, X. and Schultz, N. and Berger, M. and Scaltriti, M. and Reis-Filho, J. S. and Li, B. T. and Offit, K. and Norton, L. and Solit, D. B. and Shah, S. and Maxwell, K. N. and Couch, F. and Nathanson, K. L. and Robson, M. E. and Turner, N. C. and Chandarlapaty, S. and Razavi, P.},
  year = {2024},
  doi = {10.1101/2024.02.05.578934},
  url = {https://www.biorxiv.org/content/10.1101/2024.02.05.578934v1},
  note = {Source identifier: 10.1101/2024.02.05.578934}
}